Navigation Links
Webinar: Blood-Based Proteomic Classifier for the Molecular Characterization of Pulmonary Nodules, a Case Study in the Discovery and Validation of a Molecular Diagnostic
Date:11/27/2013

Toronto, Canada (PRWEB) November 27, 2013

The results of a major study were published recently in Science Translational Medicine (STM), which suggest that quantifying a combination of blood proteins can distinguish between benign lung nodules and early-stage lung cancer with high probability.

In this webinar, Daniel Chelsky, Chief Scientific Officer at Caprion Proteomics, will discuss candidate identification, assay development, testing and results, beginning with the derivation of the initial list of candidates, to the identification of the five blood-based proteins, which together constitute the biomarker panel used in the commercial protein expression test, developed in collaboration with Integrated Diagnostics (InDi).

Specific topics covered by the speaker will include the use of Multiple Reaction Monitoring (MRM or SRM) technology as a critical factor in the successful development of a multi-protein classifier panel, as well as the various strategies used to ensure disease specificity and relevance in the final panel.

For more information on this webinar or to register, visit http://xtalks.com/Molecular-Characterization-of-Pulmonary-Nodules.ashx.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks, visit http://xtalks.com/ContactUs.ashx.

Contact:
Michelle Tran (416) 977-6555 ext 227
clientservices(at)xtalks(dot)com

Read the full story at http://www.prweb.com/releases/2013/11/prweb11375932.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Protiviti Webinar: Mapping Your Strategic Course - IPO or M&A?
2. Formedix to Host Webinar: Discover Define-XML - Practical Uses Today and a Technical Deep Dive on March 14, 2013
3. Blood-Based Circulating Microvesicles (cMV) Data to be Presented at the 2013 International Society for Extracellular Vesicles (ISEV)
4. Adaptive Biotechnologies launches clonoSEQ, a more sensitive, accurate assay to detect minimal residual disease (MRD) in blood-based cancers.
5. Waters Teams With Biochemical Society on Proteomics Training Day and Symposium
6. Elsevier Launches New Open Access Journal: Translational Proteomics
7. Director of Proteomics at the Broad Institute of MIT and Harvard, Steven Carr, to Deliver Pittcon 2014 Wallace H. Coulter Plenary Lecture
8. Research and Markets: Proteomics - Technologies, Markets and Companies - 2013 Report
9. Life Technologies to Accelerate Development of Ion Torrent Semiconductor Technology for Proteomic Applications in Research, Applied and Clinical Markets
10. Veracyte Announces Medicare Coverage for Its Afirma® Gene Expression Classifier for Improved Thyroid Nodule Diagnosis
11. Molecular Diagnostics - Global Strategic Business Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/11/2019)... ... June 10, 2019 , ... Advancements with Ted ... episode, scheduled to broadcast 4Q/2019. Check your local listings for more information. , ... about how its technology facilitates laboratories to improve efficiency and quality of research ...
(Date:6/11/2019)... ... June 11, 2019 , ... ... Carilion Clinic, a national leader in opioid treatment, announced today they are partnering ... , Mytonomy recently deployed its virtual care platform at the Mayo Clinic ...
(Date:6/11/2019)... , ... June 11, 2019 , ... ... derived from human mesenchymal stem cells (MSC-EV) are able to incorporate into human ... In a test on mice, MSC-EVs also increased the cells’ ability to lodge ...
(Date:5/31/2019)... ... , ... For many years, the primary forms of cancer treatment have been ... in immuno-oncology have led to the advent of Chimeric Antigen Receptor T (CAR T) ... known as “CARs”. The CAR enables the final product to produce chemicals in the ...
Breaking Biology Technology:
(Date:5/21/2019)... ... ... The ASGCT Clinical Trials Finder is a customizable search engine ... Data curated daily from ClinicalTrials.gov ensures the most up-to-date and applicable listings anywhere in ... in the development of the ASGCT Clinical Trials Finder reviewed the relevance ...
(Date:5/21/2019)... ... 2019 , ... At their May 16 meeting, the members of the F04.43 ... the American Society for Testing and Materials International voted unanimously to approve ... next step in the company’s plan to establish its AlphaSTEM Test™ stem ...
(Date:5/16/2019)... FAYETTEVILLE, Ark. (PRWEB) , ... May 16, 2019 , ... ... PercuSense, Inc., as part of the Industry Development and Discovery Partnership that was awarded ... the development of a single integrated pod artificial pancreas (AP) system for people with ...
Breaking Biology News(10 mins):